Kinarus Therapeutics announces business combination with Curatis AG and reverse share split.
Kinarus Therapeutics Holding AG releases its FY2023 financial statements, announcing the details of its business combination with Curatis AG and a reverse share split. The company also postpones the publication of its Annual Report 2023. The business combination with Curatis AG and reverse share split details, along with the final timeline for their completion, have been announced.
April 17, 2024
4 Articles